Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
(NasdaqGM:IRON), WATERTOWN, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it has commenced an underwritten offering of $200.0 million of shares of its common stock and, […]